Surgery Partners, Inc. $SGRY Stock Position Lowered by MidWestOne Financial Group Inc.

MidWestOne Financial Group Inc. trimmed its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 21.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 159,146 shares of the company’s stock after selling 44,614 shares during the period. MidWestOne Financial Group Inc.’s holdings in Surgery Partners were worth $3,444,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Surgery Partners by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 45,693 shares of the company’s stock valued at $1,085,000 after purchasing an additional 2,015 shares in the last quarter. Millennium Management LLC lifted its stake in Surgery Partners by 1,253.7% in the 1st quarter. Millennium Management LLC now owns 202,274 shares of the company’s stock worth $4,804,000 after acquiring an additional 219,806 shares in the last quarter. Empowered Funds LLC boosted its position in Surgery Partners by 11.0% during the 1st quarter. Empowered Funds LLC now owns 12,853 shares of the company’s stock worth $305,000 after acquiring an additional 1,278 shares during the period. KLP Kapitalforvaltning AS grew its stake in Surgery Partners by 22.5% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 15,800 shares of the company’s stock valued at $351,000 after acquiring an additional 2,900 shares in the last quarter. Finally, Cannon Global Investment Management LLC purchased a new position in Surgery Partners during the 2nd quarter valued at about $367,000.

Surgery Partners Stock Performance

SGRY stock opened at $15.46 on Friday. The firm has a 50 day moving average of $15.45 and a two-hundred day moving average of $18.92. Surgery Partners, Inc. has a 12 month low of $13.14 and a 12 month high of $26.16. The company has a market capitalization of $2.00 billion, a price-to-earnings ratio of -11.37 and a beta of 1.97. The company has a quick ratio of 1.72, a current ratio of 1.88 and a debt-to-equity ratio of 1.10.

Analyst Ratings Changes

SGRY has been the subject of a number of research analyst reports. Royal Bank Of Canada reduced their price target on shares of Surgery Partners from $35.00 to $31.00 and set an “outperform” rating for the company in a research report on Tuesday, November 11th. UBS Group cut their target price on shares of Surgery Partners from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Thursday, November 13th. JPMorgan Chase & Co. decreased their target price on shares of Surgery Partners from $27.00 to $20.00 and set a “neutral” rating for the company in a research note on Monday, November 24th. Benchmark dropped their price target on shares of Surgery Partners from $35.00 to $30.00 and set a “buy” rating on the stock in a research note on Tuesday, November 11th. Finally, Mizuho cut their price objective on Surgery Partners from $22.00 to $19.00 and set an “outperform” rating for the company in a report on Thursday, December 18th. Seven equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Surgery Partners has a consensus rating of “Moderate Buy” and a consensus price target of $27.11.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.